Loading
V5med
V5med makes AI software that helps radiologists spot small lung nodules, possible early lung cancers, on chest CT scans.
Also called: V5med Inc.倍智醫電V5 Technologies
Overview
V5med Inc. (倍智醫電), headquartered in Hsinchu Science Park, Taiwan, with an R&D centre in Taichung, develops AI image-reading software. Its V5-LU01 lung AI assists radiologists in detecting lung nodules on thoracic CT; a retrospective multi-reader, multi-case study compared radiologist performance with and without the software (NCT06514248), and the company reports that its lung nodule software received US FDA clearance. It also works on coronary artery imaging with Taichung Veterans General Hospital. Its first registered cancer-related study, NCT06514248, was posted on ClinicalTrials.gov in July 2024.
Notes
- Company website (Chinese) read on 29 October 2026; the FDA clearance is a company news headline and the 510(k) record was not checked. Founding year not stated. No financing found. The registered study is a reader study of lung nodule detection, not a treatment trial.
Connected
4Similar pages
- TermLung-RADS and nodule reporting
Shares AI in radiology, Lung cancer (all types).
- TermPulmonary nodule
Shares AI in radiology, Lung cancer (all types).
- TechnologyNHS Targeted Lung Health Check (lung cancer screening programme)
Shares AI in radiology, Lung cancer (all types).
- Key paperNELSON: volume-based CT screening reduces lung cancer deaths with fewer false alarms
Shares AI in radiology, Lung cancer (all types).
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
ClinicalTrials.gov · 1
v5med.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/